ADT Can Cause Nocturia or the Need to Use the Bathroom at Night

One of the common and constant complaints I hear at prostate cancer support groups is about the need to wake during the night and use the bathroom to urinate (nocturia). There is a relationship between our ageing and the need to urinate at night, but it does seem to be made even more acute if [...]

Metastatic Prostate Cancer Mortality Rates Unchanged – But Fewer Men Are Becoming Metastatic

The PSA controversy continues to plague men’s health. The United States Preventive Task Force’s recommendation against using the PSA blood test as a screening tool for prostate cancer (PCa) will bring additional harms to men. Since the beginning of PSA testing the mortality rate from prostate cancer has declined significantly, but there has been no [...]

Using Circulating Tumor Cells as a Prognostic Tool – Better than PSA

Better prediction tools to predict treatment outcome in men with metastatic castration-resistant prostate cancer (mCRPC) should significantly improve treatment outcomes. Without good predictive measures we often don't know when is the optimum time to stop a therapy and move to another. This means that we might maturely stop an effective treatment losing the effectiveness of [...]

Does Debulking A Tumor When Initially Diagnosed with Advanced Prostate Cancer Offer An Advantage?

Men initially diagnosed with advanced prostate cancer often face a serious question, whether traditional primary treatments that would remove or make smaller their primary tumor (“debulking” the tumor) provide any advantage or extend their survival. Since the most commonly used method to debulk tumors is surgery or radiation the question becomes if the risks of [...]

Predicting Survival in Men with Spinal Cord Compression from Metastatic Prostate Cancer

There was a recent study to investigate the predictive value of the number of extra-spinal organs involved by metastases for survival in metastatic spinal cord compression (MSCC) from prostate cancer. This was a very small study of only 95 men irradiated with 10×3 Gy for MSCC from prostate cancer. The investigators considered seven factors: Age, [...]

Go to Top